Archives of Clinical Infectious Diseases

Published by: Kowsar

Efficiency of Helicobacter pylori Infection Treatment Protocol: Clarithromycin, Amoxicillin and Omeprazole

Parviz Saleh 1 , Armin Zarrintan 2 , 3 , Ali Hossein Zeinal Zade 4 , Reza Piri 2 , 3 , Sahar Mohammadi 3 and Mohammad Naghavi-Behzad 5 , *
Authors Information
1 Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Student Research Committee, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Department of Community Medicine, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: December 24, 2012, 8 (1); 14-7
  • Published Online: December 24, 2012
  • Article Type: Research Article
  • Received: September 4, 2012
  • Revised: November 13, 2012
  • Accepted: December 1, 2012
  • DOI: 10.5812/archcid.14408

To Cite: Saleh P, Zarrintan A, Zeinal Zade A H, Piri R, Mohammadi S, et al. Efficiency of Helicobacter pylori Infection Treatment Protocol: Clarithromycin, Amoxicillin and Omeprazole, Arch Clin Infect Dis. 2012 ; 8(1):14-7. doi: 10.5812/archcid.14408.

Abstract
Copyright © 2012, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison's™ Principles of Internal Medicine. 2012;
  • 2. Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol. 2010; 105(1): 65-73[DOI][PubMed]
  • 3. Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Minerva Med. 2006; 97(1): 39-45[PubMed]
  • 4. Deron E, Kiec-Swierczynska M. [The role of Helicobacter pyroli in the development of skin diseases]. Med Pr. 2002; 53(4): 333-7[PubMed]
  • 5. Saleh P, Bastani P, Piri R, Goldust M, Naghavi-Behzad M. Antimicrobial prophylaxis for surgical site infections in surgical wards in North-West Iran. Life Sci J. 2013; 10(2): 1977-1981
  • 6. Essa AS, Kramer JR, Graham DY, Treiber G. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter. 2009; 14(2): 109-18[DOI][PubMed]
  • 7. Delport W, van der Merwe SW. The transmission of Helicobacter pylori: the effects of analysis method and study population on inference. Best Pract Res Clin Gastroenterol. 2007; 21(2): 215-36[DOI][PubMed]
  • 8. Graham DY, Yamaoka Y, Malaty HM. Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 2007; 101(9): 849-51[DOI][PubMed]
  • 9. Saleh P, Azari-Yam S, Naghavi-Behzad M. The correspondence between pneumonia severity index (PSI) and quantitative C-Reactive protein in patients with pneumonia. Tabriz U Med Sci Health Serv. 2013; 35(2): 56-63
  • 10. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007; 445(7130): 915-8[DOI][PubMed]
  • 11. Goodman KJ, Correa P. Transmission of Helicobacter pylori among siblings. The Lancet. 2000; 355(9201): 358-62
  • 12. Egan BJ, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter. 2008; 13 Suppl 1: 35-40[DOI][PubMed]
  • 13. Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102(8): 1808-25[DOI][PubMed]
  • 14. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56(6): 772-81[DOI][PubMed]
  • 15. Ramteke S, Jain NK. Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori. J Drug Target. 2008; 16(1): 65-72[DOI][PubMed]
  • 16. O'Connor A, Gisbert JP, McNamara D, O'Morain C. Treatment of Helicobacter pylori infection 2011. Helicobacter. 2011; 16 Suppl 1: 53-8[DOI][PubMed]
  • 17. Aminian K, Farsad F, Ghanbari A, Fakhreih S, Hasheminasab SM. A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. Trop Gastroenterol. 2010; 31(4): 303-7
  • 18. Okada M, Nishimura H, Kawashima M, Okabe N, Maeda K, Seo M, et al. A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome. Aliment Pharm Therap. 1999; 13(6): 769-74[DOI]
  • 19. Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharm Therap. 2003; 17(5): 719-26[DOI]
  • 20. Hung IF, Chan P, Leung S, Chan FS, Hsu A, But D, et al. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Helicobacter. 2009; 14(6): 505-11[DOI][PubMed]
  • 21. Sanches B, Coelho L, Moretzsohn L, Vieira G, Jr. Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. Helicobacter. 2008; 13(6): 572-6[DOI][PubMed]
  • 22. Ghadir MR, Shafaghi A, Iranikhah A, Pakdin A, Joukar F, Mansour-Ghanaei F. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease. Turk J Gastroenterol. 2011; 22(1): 1-5[PubMed]
  • 23. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002; 31(1): 128-39[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments